Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ralph Corey

Showing results (91-100 of 157) with videos related to

Pageof 16
Sort By:
American Journal of Infection Control|May 22, 2012
Epidemiology and outcome of major postoperative infections following cardiac surgery: risk factors and impact of pathogen typeLuke F Chen, Jean Marie Arduino, Shubin Sheng, et al.
International Journal of Antimicrobial Agents|July 30, 2013
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumoniaMartin E Stryjewski, Steven L Barriere, Ethan Rubinstein, et al.
The New England Journal of Medicine|June 5, 2014
Single-dose oritavancin in the treatment of acute bacterial skin infectionsG Ralph Corey, Heidi Kabler, Purvi Mehra, et al.
The American Journal of Medicine|March 5, 2005
Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremiaFadi El-Ahdab, Daniel Kelly Benjamin, Andrew Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2005
Repeat infective endocarditis: differentiating relapse from reinfectionVivian H Chu, Daniel J Sexton, Christopher H Cabell, et al.
Journal of Medical Microbiology|March 21, 2020
A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infectionsStephanie Noviello, G Ralph Corey, Thomas L Holland, et al.
Archives of Internal Medicine|February 5, 2002
Changing patient characteristics and the effect on mortality in endocarditisChristopher H Cabell, James G Jollis, Gail E Peterson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2009
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxicSara E Cosgrove, Gloria A Vigliani, Vance G Fowler, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 7, 2016
An Approach to Improve the Negative Predictive Value and Clinical Utility of Transthoracic Echocardiography in Suspected Native Valve Infective EndocarditisJoseph A Sivak, Amit N Vora, Ann Marie Navar, et al.
JACC. Clinical Electrophysiology|January 22, 2021
Clinical Presentation, Timing, and Microbiology of CIED Infections: An Analysis of the WRAP-IT TrialM Rizwan Sohail, G Ralph Corey, Bruce L Wilkoff, et al.
Pageof 16

Showing results (91-100 of 157) with videos related to

Sort By:
Pageof 16
American Journal of Infection Control|May 22, 2012
Epidemiology and outcome of major postoperative infections following cardiac surgery: risk factors and impact of pathogen typeLuke F Chen, Jean Marie Arduino, Shubin Sheng, et al.
International Journal of Antimicrobial Agents|July 30, 2013
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumoniaMartin E Stryjewski, Steven L Barriere, Ethan Rubinstein, et al.
The New England Journal of Medicine|June 5, 2014
Single-dose oritavancin in the treatment of acute bacterial skin infectionsG Ralph Corey, Heidi Kabler, Purvi Mehra, et al.
The American Journal of Medicine|March 5, 2005
Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremiaFadi El-Ahdab, Daniel Kelly Benjamin, Andrew Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2005
Repeat infective endocarditis: differentiating relapse from reinfectionVivian H Chu, Daniel J Sexton, Christopher H Cabell, et al.
Journal of Medical Microbiology|March 21, 2020
A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infectionsStephanie Noviello, G Ralph Corey, Thomas L Holland, et al.
Archives of Internal Medicine|February 5, 2002
Changing patient characteristics and the effect on mortality in endocarditisChristopher H Cabell, James G Jollis, Gail E Peterson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2009
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxicSara E Cosgrove, Gloria A Vigliani, Vance G Fowler, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 7, 2016
An Approach to Improve the Negative Predictive Value and Clinical Utility of Transthoracic Echocardiography in Suspected Native Valve Infective EndocarditisJoseph A Sivak, Amit N Vora, Ann Marie Navar, et al.
JACC. Clinical Electrophysiology|January 22, 2021
Clinical Presentation, Timing, and Microbiology of CIED Infections: An Analysis of the WRAP-IT TrialM Rizwan Sohail, G Ralph Corey, Bruce L Wilkoff, et al.
Pageof 16